Description
PRINCIPIO ACTIVO: CLONIXINATO DE LISINA
indicado para el tratamiento de la diabetes mellitus tipo 2 en adultos cuando el control glucémico no se logra adecuadamente con monoterapia
PRINCIPIO ACTIVO: LEVOCARNITINA
🏭 Fabricante
ZINCOLSET 10 TAB 8 MG BE ADVANCE PRINCIPIO ACTIVO: CLONIXINATO DE LISINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
